1Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol, 2011,204 : 134, e1-e20.
同被引文献40
1乐杰.妇产科学[M].北京:人民卫生出版社,2010:89.
2Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment ofpreterm labor [J]. Int J Gyrtaecol Obstet. 2011, 113(3): 192-195.
3Van De Water, Tlmmerman-Van Kessel, M. De Kleine, et al. Toco- lytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial [J]. Acta Obstetricia Et Gy- necolo~ica Scandinavica, 2008, 87(3): 340-345.
4Sabour S. Prediction of spontaneous preterm delivery in women with threatened preterm labour:a prospective cohort study of multiple pro- teins in maternal serum [ J ]. B JOG,2012,119 ( 12 ) : 1544.
5Hudic I, Szekeres-Bartho J, Fatusic Z, et al. Dydrogesterone supplementation in women with threatened prcterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor[J]. J Reprod Immunol,2011,92 ( 1-2 ) : 103-107.
6Phupong V,Charakorn C,Charoenvidhya D.Oral salbutamol for treatment of preterm labor.J Med Assoc Thai,2004,87:1012-1016.
7de Heus R,MoI BW,Erwich JJ,et al.Adverse drug reaction to tocolytic treatment for preterm labour:prospective cohort study.BMJ,2009,5:738-744.
